174 related articles for article (PubMed ID: 19564816)
1. Effect of noise conditioning on cisplatin-induced ototoxicity: a pilot study.
Theneshkumar S; Lorito G; Giordano P; Petruccelli J; Martini A; Hatzopoulos S
Med Sci Monit; 2009 Jul; 15(7):BR173-7. PubMed ID: 19564816
[TBL] [Abstract][Full Text] [Related]
2. Prevention of noise- and drug-induced hearing loss with D-methionine.
Campbell KC; Meech RP; Klemens JJ; Gerberi MT; Dyrstad SS; Larsen DL; Mitchell DL; El-Azizi M; Verhulst SJ; Hughes LF
Hear Res; 2007 Apr; 226(1-2):92-103. PubMed ID: 17224251
[TBL] [Abstract][Full Text] [Related]
3. Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model.
Thomas Dickey D; Muldoon LL; Kraemer DF; Neuwelt EA
Hear Res; 2004 Jul; 193(1-2):25-30. PubMed ID: 15219317
[TBL] [Abstract][Full Text] [Related]
4. The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity.
Nader ME; Théorêt Y; Saliba I
Laryngoscope; 2010 Jun; 120(6):1208-13. PubMed ID: 20513041
[TBL] [Abstract][Full Text] [Related]
5. L- and D- methionine provide equivalent long term protection against CDDP-induced ototoxicity in vivo, with partial in vitro and in vivo retention of antineoplastic activity.
Reser D; Rho M; Dewan D; Herbst L; Li G; Stupak H; Zur K; Romaine J; Frenz D; Goldbloom L; Kopke R; Arezzo J; Van De Water T
Neurotoxicology; 1999 Oct; 20(5):731-48. PubMed ID: 10591510
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of D-methionine as a cytoprotectant in cisplatin treatment of an animal model for ovarian cancer.
Cloven NG; Re A; McHale MT; Burger RA; DiSaia PJ; Rose GS; Campbell KC; Fan H
Anticancer Res; 2000; 20(6B):4205-9. PubMed ID: 11205249
[TBL] [Abstract][Full Text] [Related]
7. Effect of N-acetylcysteine on carboplatin-induced ototoxicity and nitric oxide levels in a rat model.
Okur E; Kilinc M; Yildirim I; Kilic MA; Tolun FI
Laryngoscope; 2007 Dec; 117(12):2183-6. PubMed ID: 17909450
[TBL] [Abstract][Full Text] [Related]
8. L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity.
Feghali JG; Liu W; Van De Water TR
Laryngoscope; 2001 Jul; 111(7):1147-55. PubMed ID: 11568534
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of vitamins E, B and C and L-carnitine in the prevention of cisplatin-induced ototoxicity in rats.
Tokgöz SA; Vuralkan E; Sonbay ND; Çalişkan M; Saka C; Beşalti Ö; Akin İ
J Laryngol Otol; 2012 May; 126(5):464-9. PubMed ID: 22490890
[TBL] [Abstract][Full Text] [Related]
10. Different strategies in treating noiseinduced hearing loss with N-acetylcysteine.
Lorito G; Giordano P; Petruccelli J; Martini A; Hatzopoulos S
Med Sci Monit; 2008 Aug; 14(8):BR159-64. PubMed ID: 18667992
[TBL] [Abstract][Full Text] [Related]
11. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
Dickey DT; Wu YJ; Muldoon LL; Neuwelt EA
J Pharmacol Exp Ther; 2005 Sep; 314(3):1052-8. PubMed ID: 15951398
[TBL] [Abstract][Full Text] [Related]
12. Future opportunities in preventing cisplatin induced ototoxicity.
van den Berg JH; Beijnen JH; Balm AJ; Schellens JH
Cancer Treat Rev; 2006 Aug; 32(5):390-7. PubMed ID: 16781082
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients.
Yoo J; Hamilton SJ; Angel D; Fung K; Franklin J; Parnes LS; Lewis D; Venkatesan V; Winquist E
Laryngoscope; 2014 Mar; 124(3):E87-94. PubMed ID: 23946126
[TBL] [Abstract][Full Text] [Related]
14. Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma.
Kushner BH; Budnick A; Kramer K; Modak S; Cheung NK
Cancer; 2006 Jul; 107(2):417-22. PubMed ID: 16779793
[TBL] [Abstract][Full Text] [Related]
15. Aminoguanidine prevents ototoxicity induced by cisplatin in rats.
Iraz M; Kalcioglu MT; Kizilay A; Karatas E
Ann Clin Lab Sci; 2005; 35(3):329-35. PubMed ID: 16081592
[TBL] [Abstract][Full Text] [Related]
16. d-Methionine protects against cisplatin-induced neurotoxicity in cortical networks.
Gopal KV; Wu C; Shrestha B; Campbell KC; Moore EJ; Gross GW
Neurotoxicol Teratol; 2012; 34(5):495-504. PubMed ID: 22732230
[TBL] [Abstract][Full Text] [Related]
17. Targeted amelioration of cisplatin-induced ototoxicity in guinea pigs.
Mohan S; Smyth BJ; Namin A; Phillips G; Gratton MA
Otolaryngol Head Neck Surg; 2014 Nov; 151(5):836-9. PubMed ID: 25078416
[TBL] [Abstract][Full Text] [Related]
18. Transtympanic injections of N-acetylcysteine for the prevention of cisplatin-induced ototoxicity: a feasible method with promising efficacy.
Riga MG; Chelis L; Kakolyris S; Papadopoulos S; Stathakidou S; Chamalidou E; Xenidis N; Amarantidis K; Dimopoulos P; Danielides V
Am J Clin Oncol; 2013 Feb; 36(1):1-6. PubMed ID: 22134515
[TBL] [Abstract][Full Text] [Related]
19. Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration.
Reddel RR; Kefford RF; Grant JM; Coates AS; Fox RM; Tattersall MH
Cancer Treat Rep; 1982 Jan; 66(1):19-23. PubMed ID: 7198012
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of cisplatin ototoxicity and progress in otoprotection.
Rybak LP
Curr Opin Otolaryngol Head Neck Surg; 2007 Oct; 15(5):364-9. PubMed ID: 17823555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
